These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7618125)

  • 21. [Quantitative toxicologic evaluation of poisons in the human cell culture].
    Shpirt MB
    Gig Sanit; 1977 Apr; (4):50-3. PubMed ID: 892475
    [No Abstract]   [Full Text] [Related]  

  • 22. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of Haber's law in standard setting and risk assessment.
    Gaylor DW
    Toxicology; 2000 Aug; 149(1):17-9. PubMed ID: 10963857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of occupational neurobehavioural hazards. Methodological experiences from organic solvent research.
    Hogstedt C; Lundberg I
    Rev Epidemiol Sante Publique; 1992; 40 Suppl 1():S7-16. PubMed ID: 1626108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A search for thresholds and other nonlinearities in the relationship between hexavalent chromium and lung cancer.
    Park RM; Stayner LT
    Risk Anal; 2006 Feb; 26(1):79-88. PubMed ID: 16492182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical toxicity and chemical carcinogenesis. Is there a causal connection? A comparative morphological evaluation of 1500 experiments.
    Huff JE
    IARC Sci Publ; 1992; (116):437-75. PubMed ID: 1428093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Petroleum hydrocarbon toxicity studies. III. Animal and human response to vapors of Stoddard solvent.
    Carpenter CP; Kinkead ER; Geary DL; Sullivan LJ; King JM
    Toxicol Appl Pharmacol; 1975 May; 32(2):282-97. PubMed ID: 1154394
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further development of the theory and mathematical description of combined toxicity: An approach to classifying types of action of three-factorial combinations (a case study of manganese-chromium-nickel subchronic intoxication).
    Katsnelson BA; Panov VG; Minigaliyeva IA; Varaksin AN; Privalova LI; Slyshkina TV; Grebenkina SV
    Toxicology; 2015 Aug; 334():33-44. PubMed ID: 26004978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotoxicity of organic solvents: biomarkers for early detection.
    Voss JU; Roller M; Brinkmann E; Mangelsdorf I
    Int Arch Occup Environ Health; 2005 Jul; 78(6):475-85. PubMed ID: 15895243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. U-shaped dose-response curves: their occurrence and implications for risk assessment.
    Davis JM; Svendsgaard DJ
    J Toxicol Environ Health; 1990 Jun; 30(2):71-83. PubMed ID: 2192070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of exposure to vapours of standard and dearomatized white spirits in humans. 1. Dose-finding study.
    Ernstgård L; Lind B; Johanson G
    J Appl Toxicol; 2009 Apr; 29(3):255-62. PubMed ID: 19086014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammary gland neoplasia in long-term rodent studies.
    Russo IH; Russo J
    Environ Health Perspect; 1996 Sep; 104(9):938-67. PubMed ID: 8899375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene.
    Barton HA; Das S
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):269-85. PubMed ID: 8975757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical markers of neurotoxicity: research strategies and epidemiological applications.
    Costa LG; Manzo L
    Toxicol Lett; 1995 May; 77(1-3):137-44. PubMed ID: 7618127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary excretion of chromium in workers in the chromium salt industry].
    Mambetalin ES; Nuftiev IN; Kurmangaliev OM; Buchkova NI
    Gig Tr Prof Zabol; 1988 Nov; (11):55-7. PubMed ID: 3234837
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of occupational exposure to organic solvents on kidney function.
    Jakubowski M
    Int J Occup Med Environ Health; 2005; 18(1):5-14. PubMed ID: 16052886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.